BNP Paribas Financial Markets
TMCI icon

BNP Paribas Financial Markets’s Treace Medical Concepts TMCI Stock Holding History

BNP Paribas Financial Markets’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273K Buy
68,580
+50,950
+289% +$140K ﹤0.01% 4090
2026
Q1 		$23.6K Sell
17,630
-36,339
-67% -$72.4K ﹤0.01% 5038
2025
Q4 		$132K Sell
53,969
-170,812
-76% -$742K ﹤0.01% 4242
2025
Q3 		$1.51M Buy
224,781
+61,805
+38% +$404K ﹤0.01% 2831
2025
Q2 		$958K Buy
162,976
+7,898
+5% +$51.5K ﹤0.01% 2935
2025
Q1 		$1.3M Buy
155,078
+75,726
+95% +$681K ﹤0.01% 2596
2024
Q4 		$590K Buy
+79,352
New +$531K ﹤0.01% 3181

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $118M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BNP Paribas Financial Markets's TMCI Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Treace Medical Concepts (TMCI) stake by 289% in Q2 2026, buying an estimated $140K and bringing the position to 68,580 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #4090.

BNP Paribas Financial Markets first reported a position in TMCI in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.51M in Q3 2025. 107 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • BNP Paribas Financial Markets held 68,580 shares of Treace Medical Concepts worth $273K as of Q2 2026.
  • BNP Paribas Financial Markets bought 50,950 Treace Medical Concepts shares in Q2 2026, an estimated $140K.
  • Treace Medical Concepts made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4090 holding.
  • BNP Paribas Financial Markets first reported a position in Treace Medical Concepts in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Treace Medical Concepts position peaked at $1.51M in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.